Advertisement

Topics

Innovus Pharma Launches FlutiCare™ OTC Nasal Spray Allergy Relief in the U.S.

06:05 EST 14 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Product Currently Expected to Generate $10-15M in Additional Revenues Annually Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutic...

Other Sources for this Article

Emerging Markets Consulting, LLC
James S. Painter III, 407 340 0226
jamespainter@emergingmarketsllc.com
or
myEPK Media
Matt Anthes
424 256 9375
Matt@myEPKMedia.com

NEXT ARTICLE

More From BioPortfolio on "Innovus Pharma Launches FlutiCare™ OTC Nasal Spray Allergy Relief in the U.S."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...